Antonio Pellicer Selected Research

Birth Weight (Birth Weights)

1/2023

Preimplantation genetic testing for aneuploidy is not related to adverse obstetric and neonatal outcomes in singleton pregnancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Pellicer Research Topics

Disease

22	Endometriosis 11/2023 - 01/2002
20	Ovarian Hyperstimulation Syndrome 09/2015 - 11/2002
15	Neoplasms (Cancer) 12/2023 - 06/2003
10	Leiomyoma (Uterine Fibroids) 01/2023 - 09/2008
9	Infertility (Sterility) 01/2023 - 10/2005
7	Spontaneous Abortion (Miscarriage) 01/2023 - 07/2005
6	Adenomyosis 01/2024 - 11/2022
6	Pre-Eclampsia (Preeclampsia) 01/2024 - 06/2006
5	Aneuploidy (Aneuploid) 11/2023 - 01/2017
5	Ectopic Pregnancy 01/2019 - 03/2010
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2022 - 06/2006
3	COVID-19 12/2022 - 01/2022
3	Inflammation (Inflammations) 12/2022 - 03/2011
3	Gynatresia 11/2022 - 05/2016
3	Atrophy 11/2021 - 12/2015
3	Male Infertility (Male Sterility) 05/2008 - 10/2005
3	Body Weight (Weight, Body) 06/2006 - 11/2003
3	Chromosome Aberrations (Chromosome Abnormalities) 10/2005 - 11/2003
3	Habitual Abortion (Recurrent Miscarriage) 10/2005 - 05/2003
2	Insulin Resistance 01/2023 - 05/2006
2	Primary Ovarian Insufficiency 11/2022 - 01/2019
2	Pain (Aches) 01/2021 - 02/2015
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2020 - 02/2019
2	Breast Neoplasms (Breast Cancer) 12/2015 - 01/2010
2	Down Syndrome (Down's Syndrome) 11/2013 - 09/2005
2	Hyperprolactinemia 03/2011 - 11/2006
2	Ascites 04/2010 - 08/2007
2	Thrombophilia 02/2008 - 10/2002
1	Pregnancy Complications 01/2023
1	Premature Birth (Birth, Premature) 01/2023
1	Birth Weight (Birth Weights) 01/2023
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	Polyps 11/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022

Drug/Important Bio-Agent (IBA)

16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 11/2002
8	Hormones (Hormone)IBA 11/2023 - 03/2010
8	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 08/2007
7	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023 - 05/2007
6	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
6	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2012
5	Progesterone FDA LinkGeneric 11/2023 - 01/2002
5	Cabergoline FDA LinkGeneric 01/2021 - 08/2007
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2005
5	Dopamine Receptors (Dopamine Receptor)IBA 11/2014 - 11/2006
5	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 03/2011 - 11/2002
4	Mitochondrial DNA (mtDNA)IBA 11/2023 - 01/2018
4	CateninsIBA 01/2023 - 01/2019
4	quinagolideIBA 01/2021 - 04/2010
4	LeptinIBA 06/2006 - 05/2004
3	Aromatase InhibitorsIBA 11/2023 - 01/2021
3	Estradiol (Delestrogen)FDA LinkGeneric 11/2023 - 07/2005
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2020
3	Vitamin D FDA LinkGeneric 01/2021 - 01/2019
3	SteroidsIBA 01/2021 - 09/2008
3	GonadotropinsIBA 01/2017 - 11/2006
3	Prostaglandins DIBA 01/2017 - 04/2005
3	Messenger RNA (mRNA)IBA 01/2014 - 01/2002
3	Estrogens (Estrogen)FDA Link 01/2010 - 10/2002
2	Histones (Histone)IBA 01/2023 - 05/2022
2	CytokinesIBA 12/2022 - 01/2015
2	Biocompatible Materials (Biomaterials)IBA 11/2022 - 11/2021
2	HydrogelsIBA 11/2022 - 11/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
2	Plasminogen Activator Inhibitor 1IBA 01/2021 - 01/2018
2	AntioxidantsIBA 01/2021 - 07/2012
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2020 - 02/2019
2	Lysine (L-Lysine)FDA Link 12/2016 - 11/2015
2	CreatinineIBA 12/2016 - 11/2015
2	Valine (L-Valine)FDA Link 12/2016 - 11/2015
2	Double-Stranded RNA (RNA, Double Stranded)IBA 02/2016 - 11/2015
2	polycationsIBA 02/2016 - 11/2015
2	PolyethyleneimineIBA 02/2016 - 11/2015
2	Poly CIBA 02/2016 - 11/2015
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 11/2013 - 09/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2011 - 03/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2009 - 06/2003
2	Oxidoreductases (Dehydrogenase)IBA 02/2008 - 01/2002
1	Inositol (Myoinositol)IBA 01/2024
1	histone H3 trimethyl Lys4IBA 01/2023
1	Letrozole (Femara)FDA LinkGeneric 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	mRNA VaccinesIBA 10/2022
1	SirtuinsIBA 01/2022
1	Vorinostat FDA Link 01/2022
1	Viral RNAIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Decitabine FDA Link 07/2021
1	Progestins (Progestagens)IBA 01/2021
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021

Therapy/Procedure

11	Therapeutics 11/2021 - 03/2004
6	Drug Therapy (Chemotherapy) 12/2023 - 01/2010
4	Uterine Myomectomy 01/2022 - 02/2007
3	Transplantation 02/2016 - 11/2010
2	Cystectomy 01/2021 - 05/2004
2	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2016 - 12/2015
2	Aftercare (After-Treatment) 01/2014 - 08/2007
2	Radiotherapy 01/2010 - 03/2006
1	Cesarean Section (Caesarean Section) 01/2023
1	Hysterectomy 01/2022